Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accounts Payables: 2023-2025

Historic Accounts Payables for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $4.0 million.

  • Upstream Bio's Accounts Payables fell 19.33% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 19.33%. This contributed to the annual value of $4.0 million for FY2024, which is 103.07% up from last year.
  • Latest data reveals that Upstream Bio reported Accounts Payables of $4.0 million as of Q3 2025, which was up 54.92% from $2.6 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Accounts Payables peaked at $4.9 million during Q3 2024, and registered a low of $2.0 million during Q4 2023.
  • For the 3-year period, Upstream Bio's Accounts Payables averaged around $3.7 million, with its median value being $4.0 million (2024).
  • As far as peak fluctuations go, Upstream Bio's Accounts Payables skyrocketed by 103.07% in 2024, and later declined by 19.33% in 2025.
  • Over the past 3 years, Upstream Bio's Accounts Payables (Quarterly) stood at $2.0 million in 2023, then soared by 103.07% to $4.0 million in 2024, then fell by 19.33% to $4.0 million in 2025.
  • Its Accounts Payables was $4.0 million in Q3 2025, compared to $2.6 million in Q2 2025 and $4.7 million in Q1 2025.